Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesA pilot study of rizatriptan and visually-induced motion sickness in migraineurs
International Journal of Medical Sciences , 08/10/09
Furman JM et al. – The pilot data suggest that rizatriptan does not consistently reduce visually–induced motion sickness in migraineurs. Rizatriptan may diminish motion sickness potentiation by cranial pain.
Related Articles
Elevated Saliva Calcitonin Gene-Related Peptide Levels During Acute Migraine Predict Therapeutic Response to Rizatriptan
Headache: The Journal of Head and Face Pain, 10/15/09
Relevance Score: 89%
Expanding Access to Triptans: Assessment of Clinical Outcome
Headache: The Journal of Head and Face Pain, 10/12/09
Relevance Score: 84%
Study Could Change How Migraines are Diagnosed
Internet Source, 10/02/09
Relevance Score: 80%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
Anesthesiology, 12/17/09
Antiretroviral Medications: Adverse Effects on the Kidney
Advances In Chronic Kidney Disease , 12/17/09
Bilateral Acute Angle-closure Glaucoma in a Migraine Patient Receiving Topiramate: A Case Report
The Journal of Emergency Medicine, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor